Skip to main content
A | INDIA RATING AND RESEARCH PVT. LTD. NCD Secured

Dishman Carbogen Amcis Ltd.

ISIN: INE385W07067
11.25%
YTM
N/A
Minimum investment
Quarterly
Payout
09 Dec 2027
Maturity
10.00%
Coupon Rate
₹1,00,000
Face Value
11.25% / +125 bpsYTM vs coupon

yield above stated coupon

N/AClean / dirty price

Excluding / including accrued interest

About the issuer

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and providing contract development and manufacturing services. Established in 1983, the company operates globally with facilities in India, Europe, and China, serving pharmaceutical and biopharmaceutical clients. Dishman Carbogen Amcis Ltd is listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).

Issuance date
09 Jun 2026

Get in touch

Share your details and we'll connect with you about this bond.

Similar bonds

Blogs

Stay informed with the latest articles, news, and resources across finance, fixed income and investing.

Equirize Logo

EquiRize Securities Private Limited.

Get the EquiRize Investor App

  • Download on the App Store
  • Get it on Google Play

Legal & Compliance

Quick Links

Help

  • SEBI Registered

  • RBI Regulated FDs

  • Member with BSE & NSE

Corp Office:SCO: 50-51, Floor 3, Sector 34-A, Chandigarh- 160022

Registered Office: 301 Chawla Complex Commercial Premises, Sector 15, CBD Belapur, Navi Mumbai 400614 Maharashtra

© 2026 EquiRize. All rights reserved. | CIN: U66190MH2024PTC430982 | SEBI Registration Number (Stock Broker): INZ000323730 | BSE Membership No. 6914 - Debt Segment | NSE Membership No. 90472 - Debt Segment

Compliance Officer:

Lavanya Sharma

compliance@EquiRize.com, +91-9063459052

Fixed returns do not constitute guaranteed or assured returns. Investments in corporate debt securities, municipal debt securities/securitised debt instruments are subject to credit risks, market risks and default risks including delay and/or default in payment. Read all the offer related documents carefully.

Complaint Redressal via SEBI SCORES:

  • (i) Register on the SCORES portal at scores.sebi.gov.in
  • (ii) Mandatory details: Name, PAN, Address, Mobile Number, Email ID
  • (iii) Benefits: Transparent communication and faster resolution of grievances

Investor Protection Guidelines:

  1. Prevent Unauthorised Transactions:
    • Update your mobile number and email ID with your Stock Broker and Depository Participant.
    • Receive transaction alerts directly from the Exchange and NSDL/CDSL the same day.
  2. IPO Application Process:
    • No need to issue a cheque. Mention your bank account number and sign the IPO application form to authorise payment via ASBA.
    • In case of non-allotment, funds remain in your bank account.
  3. KYC Compliance:
    • KYC is a one-time process. Once completed with a SEBI-registered intermediary (broker, DP, mutual fund, etc.), it is valid across all intermediaries.
  4. Stay Vigilant:
    • Beware of fraudsters sending bulk messages with fake investment tips or promises of guaranteed returns.
    • Do not engage in unauthorised portfolio management or collective investment schemes promising fixed/guaranteed returns.

Important Note: Fixed Deposits (FDs) and Peer to Peer (P2P) Lending are not exchange-traded products. EquiRize Securities solely connects investors/lenders with said products.

Digital Accessibility

We are committed to ensuring that our digital platforms are accessible to all users, including persons with disabilities, in line with applicable SEBI guidelines.

For any accessibility-related assistance or concerns, please contact:

Attention Investors:

  • Stock Brokers can accept securities as margin only through pledge in the depository system (w.e.f. September 1, 2020).
  • Ensure your contact details are updated to receive OTPs directly from NSDL/CDSL for pledge creation.
  • Review your holdings regularly via the Consolidated Account Statement issued monthly by NSDL/CDSL.

Useful Links:

Issued in the interest of investors by EquiRize Securities Private Limited.